Press Releases

Year

Jun 06, 2008

EGM Chairman's Address

Jun 06, 2008

Scheme Meeting Chairman's Address

Jun 04, 2008

Change to Indicative timetable for Scheme of Arrangement

May 19, 2008

pSivida to present at the Rodman & Renshaw Healthcare Conference in Monte Carlo

May 09, 2008

pSivida new trial to treat AMD (age related macular degeneration)

May 06, 2008

Shareholder Meeting - 6 June 2008

Apr 30, 2008

March Quarter, 2008 Commentary & Highlights

Apr 18, 2008

pSivida proposed reincorporation in the US

Apr 15, 2008

pSivida clears Opes Prime overhang

Mar 27, 2008

pSivida appoints new Company Secretary

Mar 19, 2008

Open Briefing®. pSivida. Alimera Agreement Amendment

Mar 17, 2008

pSivida generates up to A$82m from licensing amendment with Alimera

Feb 25, 2008

pSivida to present at Sachs Conference - Boston

Feb 20, 2008

pSivida receives first R&D payments from Pfizer

Jan 31, 2008

pSivida Quarterly Cash Flow – 31 December 2007 Commentary and Highlights

Jan 29, 2008

pSivida pancreatic cancer results released

Jan 23, 2008

BrachySil in Pancreatic Cancer Study Results to be presented at the ASCO Gastrointestinal Cancers Symposium

Jan 21, 2008

pSivida sells pSiNutria to Intrinsiq(UK)

Previous page
…
Page 28
Page 29
Current page 30

Displaying 581 - 598 of 598

News releases are posted on the Company's website as soon as possible after the release over the news wire. You should view the Financial Information section and most recent SEC Filings in the Investors section to receive the most current information made available by EyePoint Pharmaceuticals, Inc.